Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Erice

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|October 3, 1998
Concentration-controlled zidovudine therapyC V Fletcher, E P Acosta, K Henry, et al.
Human Immunology|January 8, 2026
Potential synergistic role of pre-formed GSTT1 antibodies and de novo HLA antibodies in a heart-transplant recipient diagnosed with AMRNilesh S Chitnis, Maanika Nunugonda, Catherine Foye, et al.
The New England Journal of Medicine|September 26, 1991
An outbreak of herpes gladiatorum at a high-school wrestling campE A Belongia, J L Goodman, E J Holland, et al.
Elife|May 9, 2024
Downregulation of <i>Mirlet7</i> miRNA family promotes Tc17 differentiation and emphysema via de-repression of RORγtPhillip A Erice, Xinyan Huang, Matthew J Seasock, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Downregulation of <i>Let-7</i> miRNA promotes Tc17 differentiation and emphysema via de-repression of RORγtPhillip A Erice, Xinyan Huang, Matthew J Seasock, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 2, 1998
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study TeamK Henry, A Erice, C Tierney, et al.
Transplantation|January 11, 1991
Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovirD L Dunn, J L Mayoral, K J Gillingham, et al.
Revista Clinica Espanola|June 23, 2018
Prognosis of venous thromboembolism in orthopaedic surgery or trauma patients and use of thromboprophylaxisJ Gutiérrez Guisado, J Trujillo-Santos, J I Arcelus, et al.
Transplantation|March 27, 1994
A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantationD L Dunn, K J Gillingham, M A Kramer, et al.
Annals of Internal Medicine|June 15, 1997
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy TeamM D Hughes, V A Johnson, M S Hirsch, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|October 3, 1998
Concentration-controlled zidovudine therapyC V Fletcher, E P Acosta, K Henry, et al.
Human Immunology|January 8, 2026
Potential synergistic role of pre-formed GSTT1 antibodies and de novo HLA antibodies in a heart-transplant recipient diagnosed with AMRNilesh S Chitnis, Maanika Nunugonda, Catherine Foye, et al.
The New England Journal of Medicine|September 26, 1991
An outbreak of herpes gladiatorum at a high-school wrestling campE A Belongia, J L Goodman, E J Holland, et al.
Elife|May 9, 2024
Downregulation of <i>Mirlet7</i> miRNA family promotes Tc17 differentiation and emphysema via de-repression of RORγtPhillip A Erice, Xinyan Huang, Matthew J Seasock, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Downregulation of <i>Let-7</i> miRNA promotes Tc17 differentiation and emphysema via de-repression of RORγtPhillip A Erice, Xinyan Huang, Matthew J Seasock, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 2, 1998
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study TeamK Henry, A Erice, C Tierney, et al.
Transplantation|January 11, 1991
Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovirD L Dunn, J L Mayoral, K J Gillingham, et al.
Revista Clinica Espanola|June 23, 2018
Prognosis of venous thromboembolism in orthopaedic surgery or trauma patients and use of thromboprophylaxisJ Gutiérrez Guisado, J Trujillo-Santos, J I Arcelus, et al.
Transplantation|March 27, 1994
A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantationD L Dunn, K J Gillingham, M A Kramer, et al.
Annals of Internal Medicine|June 15, 1997
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy TeamM D Hughes, V A Johnson, M S Hirsch, et al.
Pageof 8